AbbVie Inc. (TSX:ABBV)
Canada · Delayed Price · Currency is CAD 31.61
-0.26 (-0.82%)
At close: Feb 26, 2026
AbbVie Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 |
Depreciation & Amortization | 8,139 | 8,386 | 8,698 | 8,467 | 8,521 |
Loss (Gain) From Sale of Assets | - | - | - | -172 | -68 |
Asset Writedown & Restructuring Costs | 5,863 | 7,233 | 5,007 | 1,467 | 1,174 |
Stock-Based Compensation | 955 | 911 | 747 | 671 | 692 |
Other Operating Activities | 2,209 | 780 | 711 | 2,768 | 2,147 |
Change in Accounts Receivable | -1,490 | 207 | 66 | -1,455 | -1,321 |
Change in Inventory | -234 | -319 | -417 | -686 | -142 |
Change in Accounts Payable | 951 | 177 | 3,840 | 1,769 | 1,719 |
Change in Other Net Operating Assets | -827 | 361 | -188 | -264 | -197 |
Operating Cash Flow | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 |
Operating Cash Flow Growth | 1.19% | -17.66% | -8.43% | 9.51% | 29.50% |
Capital Expenditures | -1,214 | -974 | -777 | -695 | -787 |
Cash Acquisitions | -5,441 | -20,517 | -1,223 | -794 | -1,902 |
Investment in Securities | 41 | 482 | -22 | 92 | -21 |
Other Investing Activities | -29 | 189 | 13 | 774 | 366 |
Investing Cash Flow | -6,643 | -20,820 | -2,009 | -623 | -2,344 |
Short-Term Debt Issued | 5,297 | 5,008 | - | - | - |
Long-Term Debt Issued | 3,994 | 16,963 | - | 2,000 | 1,000 |
Total Debt Issued | 9,291 | 21,971 | - | 2,000 | 1,000 |
Short-Term Debt Repaid | -2,798 | -5,008 | - | - | - |
Long-Term Debt Repaid | -6,797 | -9,613 | -4,149 | -14,433 | -9,414 |
Total Debt Repaid | -9,595 | -14,621 | -4,149 | -14,433 | -9,414 |
Net Debt Issued (Repaid) | -304 | 7,350 | -4,149 | -12,433 | -8,414 |
Issuance of Common Stock | 172 | 214 | 180 | 262 | 244 |
Repurchase of Common Stock | -980 | -1,708 | -1,972 | -1,487 | -934 |
Common Dividends Paid | -11,657 | -11,025 | -10,539 | -10,043 | -9,261 |
Other Financing Activities | 45 | -42 | -742 | -1,102 | -674 |
Financing Cash Flow | -12,724 | -5,211 | -17,222 | -24,803 | -19,039 |
Foreign Exchange Rate Adjustments | 42 | -65 | 5 | -62 | -97 |
Net Cash Flow | -295 | -7,290 | 3,613 | -545 | 1,297 |
Free Cash Flow | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Growth | -0.09% | -19.17% | -9.01% | 10.27% | 30.97% |
Free Cash Flow Margin | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% |
Free Cash Flow Per Share | 10.05 | 10.06 | 12.44 | 13.64 | 12.38 |
Cash Interest Paid | 3,002 | 2,811 | 2,469 | 2,546 | 2,712 |
Cash Income Tax Paid | 3,626 | 4,100 | 4,700 | 2,988 | 3,648 |
Levered Free Cash Flow | 18,338 | 19,409 | 22,975 | 21,261 | 19,394 |
Unlevered Free Cash Flow | 20,146 | 21,164 | 24,365 | 22,655 | 20,908 |
Change in Working Capital | -2,362 | -2,782 | 2,813 | -94 | -1,231 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.